IQ-AI LIMITED |
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 1.35 GBX | -11.76% |
|
-18.18% | -71.28% |
| May. 10 | IQ-AI subsidiary gets rare paediatric disease designation FDA | AN |
| May. 10 | IQ-AI's Imaging Biometrics Obtains Rare Pediatric Disease Designation for Lead Drug Candidate | MT |
Days
Hours
Minutes
Seconds
-40%
on all our subscriptions*
Last Hours!
Take advantage of the offer
* See conditions on site
| Sales 2022 | 536K 679K | Sales 2023 | 609K 772K | Capitalization | 8.96M 11.35M |
|---|---|---|---|---|---|
| Net income 2022 | - 0 | Net income 2023 | - 0 | EV / Sales 2022 | 5.75 x |
| Net cash position 2022 | 252K 319K | Net cash position 2023 | 139K 176K | EV / Sales 2023 | 14.5 x |
| P/E ratio 2022 |
-6.52
x | P/E ratio 2023 |
-13.8
x | Employees | - |
| Yield 2022 * |
-
| Yield 2023 |
-
| Free-Float | 61.72% |
More Fundamentals
* Assessed data
More news
| 1 day | -11.76% | ||
| 1 week | -18.18% | ||
| Current month | -10.00% | ||
| 1 month | -10.00% | ||
| 3 months | -48.08% | ||
| 6 months | -67.07% | ||
| Current year | -71.28% |
1 week
1.20
2.00
1 month
1.202.00
Current year
1.205.15
1 year
1.205.80
3 years
1.2011.10
5 years
1.0423.13
10 years
0.9923.13
| Managers | Title | Age | Since |
|---|---|---|---|
Trevor Brown
CEO | Chief Executive Officer | 78 | 15-02-12 |
| Members of the board | Title | Age | Since |
|---|---|---|---|
Trevor Brown
CEO | Chief Executive Officer | 78 | 15-02-12 |
Vinod Kaushal
BRD | Director/Board Member | 60 | 17-01-19 |
| Director/Board Member | - | 19-12-17 |
| Date | Price | Change | Volume |
|---|---|---|---|
| 24-05-16 | 1.35 | -11.76% | 2 044 740 |
| 24-05-15 | 1.53 | -1.29% | 615,066 |
| 24-05-14 | 1.55 | 0.00% | 350,076 |
| 24-05-13 | 1.55 | -6.06% | 1,000,726 |
| 24-05-10 | 1.65 | 0.00% | 1,400,990 |
Delayed Quote London S.E., May 16, 2024 at 11:35 am EDT
More quotes
IQ-AI Limited is a Jersey-based company, which is engaged in the provision of clinical treatments to patients in the field of medical imaging diagnostics, based on technology. The Company operates through two segments: holding company expenses and medical software. Its subsidiaries include Imaging Biometrics, LLC and Stone Checker Software Limited. Imaging Biometrics, LLC is a healthcare imaging software company. In addition to providing regulatory consulting services, Imaging Biometrics, LLC supplies medical technology solutions and has a neuroimaging product portfolio. Stone Checker Software Limited is a supplier of technology solutions in the field of kidney stone analysis and kidney stone prevention.
Calendar
2024-05-29
- Annual General Meeting
| 1st Jan change | Capi. | |
|---|---|---|
| -71.28% | 4.3M | |
| -15.71% | 8.57B | |
| +65.60% | 4.3B | |
| -9.46% | 2.47B | |
| -2.16% | 2.46B | |
| -44.11% | 2.31B | |
| -7.42% | 1.93B | |
| -18.68% | 1.53B | |
| -41.75% | 1.2B | |
| +11.31% | 1.14B |
- Stock Market
- Equities
- IQAI Stock
